MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Warrant (NQ:NTRBW)

0.8500 -0.0500 (-5.56%)
Streaming Delayed Price Updated: 2:08 PM EDT, Jun 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,692
Open 0.9000
Bid (Size) 0.8500 (1,400)
Ask (Size) 1.000 (100)
Prev. Close 0.9000
Today's Range 0.8500 - 0.9250
52wk Range 0.9000 - 4.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
From Nutriband Inc.
Via GlobeNewswire

Performance

YTD
-47.2%
-47.2%
1 Month
-44.3%
-44.3%
3 Month
-34.6%
-34.6%
6 Month
-39.3%
-39.3%
1 Year
-69.6%
-69.6%

More News

Read More
News headline image
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband CEO Publishes Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
From Nutriband Inc.
Via GlobeNewswire
News headline image
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market
Via AB Newswire
News headline image
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Co-Founder Gareth Sheridan Returns as CEO
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. to Present at the MicroCap Rodeo Conference
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
From Nutriband Inc.
Via GlobeNewswire
News headline image
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
From Nutriband Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Nutriband Inc. - Warrant publicly traded?
Yes, Nutriband Inc. - Warrant is publicly traded.
What exchange does Nutriband Inc. - Warrant trade on?
Nutriband Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Warrant?
The ticker symbol for Nutriband Inc. - Warrant is NTRBW on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Warrant?
The current price of Nutriband Inc. - Warrant is 0.8500
When was Nutriband Inc. - Warrant last traded?
The last trade of Nutriband Inc. - Warrant was at 06/01/26 02:08 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story